Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $2.8 million.

  • Orthopediatrics' Capital Expenditures rose 10557.57% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year decrease of 4418.06%. This contributed to the annual value of $14.3 million for FY2024, which is 1549.35% down from last year.
  • Orthopediatrics' Capital Expenditures amounted to $2.8 million in Q3 2025, which was up 10557.57% from $3.4 million recorded in Q2 2025.
  • Over the past 5 years, Orthopediatrics' Capital Expenditures peaked at $6.7 million during Q2 2024, and registered a low of -$523000.0 during Q4 2022.
  • In the last 5 years, Orthopediatrics' Capital Expenditures had a median value of $2.8 million in 2025 and averaged $3.1 million.
  • Per our database at Business Quant, Orthopediatrics' Capital Expenditures plummeted by 13198.78% in 2022 and then skyrocketed by 83346.08% in 2023.
  • Orthopediatrics' Capital Expenditures (Quarter) stood at $1.6 million in 2021, then tumbled by 131.99% to -$523000.0 in 2022, then surged by 833.46% to $3.8 million in 2023, then tumbled by 106.83% to -$262000.0 in 2024, then skyrocketed by 1183.59% to $2.8 million in 2025.
  • Its Capital Expenditures stands at $2.8 million for Q3 2025, versus $3.4 million for Q2 2025 and $4.2 million for Q1 2025.